Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-25 @ 1:52 PM
NCT ID: NCT00526292
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00526292
Study Brief: Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
HLA Haploidentical Natural Killer Cell Infusion HLA Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Leukemia None None 4 6 6 6 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Death not associated with CTCAE term-Disease progression NOS SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Febrile neutropenia SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Glucose, high (hyperglycemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Hemoglobin SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Leukocytes (total WBC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Lymphopenia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Magnesium, high (hypermagnesemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Neutrophils/granulocytes (ANC/AGC) SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Phosphate, low (hypophosphatemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Platelets SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Potassium, high (hyperkalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View
Potassium, low (hypokalemia) SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders CTC-3.0 View